Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Reuveni

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Archives of Dermatology|August 1, 1982
Diethyltoluamide-containing insect repellent: adverse effects in worldwide useH Reuveni, P Yagupsky
Clinical Performance and Quality Health Care|June 3, 1999
Inappropriateness of cataract extraction: an analysis in two Israeli hospital settingsM Leshno, H Reuveni
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2000
Signal transduction by a nondissociable heterotrimeric yeast G proteinS Klein, H Reuveni, A Levitzki
The Journal of Cell Biology|December 21, 2000
Reversal of the Ras-induced transformed phenotype by HR12, a novel ras farnesylation inhibitor, is mediated by the Mek/Erk pathwayH Reuveni, T Geiger, B Geiger, et al.
Health Promotion International|March 29, 2018
Ethno-cultural origins, health beliefs and mothers' behavior regarding infant vaccinations in IsraelO Sarid, Y Shraga, J Cwikel, et al.
Journal of the Royal Army Medical Corps|June 20, 2007
Various contract settings and their impact on the cost of medical servicesR Magnezi, R Dankner, R Kedem, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|August 6, 1999
A model of efficient and continuous quality improvement in a clinical settingM Glezerman, A Witznitzer, H Reuveni, et al.
Bioorganic & Medicinal Chemistry|September 11, 1999
Alpha-cyanocinnamide derivatives: a new family of non-peptide, non-sulfhydryl inhibitors of Ras farnesylationE Poradosu, A Gazit, H Reuveni, et al.
Israel Journal of Medical Sciences|November 1, 1995
The intermediate care unit as a cost-effective option for the treatment of medical patients in critical conditionA Porath, H Reuveni, G Grinberg, et al.
Pediatric Dermatology|November 1, 1986
Aplasia cutis congenita in one of monozygotic twinsP Yagupsky, H Reuveni, M Karplus, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Archives of Dermatology|August 1, 1982
Diethyltoluamide-containing insect repellent: adverse effects in worldwide useH Reuveni, P Yagupsky
Clinical Performance and Quality Health Care|June 3, 1999
Inappropriateness of cataract extraction: an analysis in two Israeli hospital settingsM Leshno, H Reuveni
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2000
Signal transduction by a nondissociable heterotrimeric yeast G proteinS Klein, H Reuveni, A Levitzki
The Journal of Cell Biology|December 21, 2000
Reversal of the Ras-induced transformed phenotype by HR12, a novel ras farnesylation inhibitor, is mediated by the Mek/Erk pathwayH Reuveni, T Geiger, B Geiger, et al.
Health Promotion International|March 29, 2018
Ethno-cultural origins, health beliefs and mothers' behavior regarding infant vaccinations in IsraelO Sarid, Y Shraga, J Cwikel, et al.
Journal of the Royal Army Medical Corps|June 20, 2007
Various contract settings and their impact on the cost of medical servicesR Magnezi, R Dankner, R Kedem, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|August 6, 1999
A model of efficient and continuous quality improvement in a clinical settingM Glezerman, A Witznitzer, H Reuveni, et al.
Bioorganic & Medicinal Chemistry|September 11, 1999
Alpha-cyanocinnamide derivatives: a new family of non-peptide, non-sulfhydryl inhibitors of Ras farnesylationE Poradosu, A Gazit, H Reuveni, et al.
Israel Journal of Medical Sciences|November 1, 1995
The intermediate care unit as a cost-effective option for the treatment of medical patients in critical conditionA Porath, H Reuveni, G Grinberg, et al.
Pediatric Dermatology|November 1, 1986
Aplasia cutis congenita in one of monozygotic twinsP Yagupsky, H Reuveni, M Karplus, et al.
Pageof 3